Drawing for NEORX

USPTO serial 76479271

NEORX

Reviewed by CopyMark Law Group

Reg. 2752829Status 710
Filing date
Status date
Registration date
Aug 19, 2003
Examiner
PIGNATELLO, ELIZABETH
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NEORX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rochelle D. Alpert

ROCHELLE D ALPERT MORGAN, LEWIS & BOCKIUS, LLPONE MARKET SPEAR ST TWRSAN FRANCISCO, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic pharmaceutical products and reagents, namely biochemical and biological reagents for localizing active agents for use in pharmaceutical and scientific researchSECTION 8 - CANCELLEDJan 6, 2002
005Therapeutic, diagnostic and prophylactic pharmaceutical preparations and agents for the treatment, diagnosis and prophylaxis of cancerSECTION 8 - CANCELLEDJan 6, 2002
040Contract manufacture of pharmaceuticals, biologics, controlled substances and radioactive substances for othersSECTION 8 - CANCELLEDJan 6, 2002
042Scientific research and development of preparations, agents and biotechnology for the treatment, diagnosis and prophylaxis of cancer; conducting clinical trials; providing scientific information to scientists, physicians and health care providers; the licensing of proprietary intellectual propertySECTION 8 - CANCELLEDJan 6, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2010C8..CANCELLED SEC. 8 (6-YR)—
Mar 3, 2009CFITCASE FILE IN TICRS—
Jun 21, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 19, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 7, 2003NPUBNOTICE OF PUBLICATION—
May 6, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 13, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2003CNEAEXAMINER'S AMENDMENT MAILED—

Frequently asked questions

Related guidance